Characterization and Quantitation of DNA Adducts Resulting from the Hypoxia-activated Prodrug (HAP) CP-506 and its Amine Metabolite CP-506M
|Effective start/end date||6/1/18 → 6/30/19|
- CONVERT PHARMACEUTICALS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.